Respiratory & Systemic Diseases
Pneumology
María Jesús Cruz Carmona, Jaume Ferrer Sancho
Researchers Carles Bravo Masgoret, Maria Luiza De Souza Galvao, Susana Gomez Olles, Javier de Gracia Roldán, Maria Angeles Jiménez Fuentes, Mª Jose Jurado Luque, Patricia Lloberes Canadell, Sergi Martí Beltran, Cèlia Milà Augé, Marc Miravitlles Fernández, Victor Monforte Torres, Ferran Morell Brotad, Antonio Moreno Galdó, Fco. Javier Muñoz Gall, Ma Luisa Navarrete Álvaro, Esther Rodríguez González, Antonio Román Broto, Odile Romero Santo-Tomas, Gabriel Sampol Rubio | Researchers in training Antonio Álvarez Fernandez, Miriam Barrecheguren Fernández, Cristina Berastegui, Mario Culebras Amigo, Manuel López Meseguer, Iñigo Ojanguren Arranz, Marta Ollé Monge, Mercedes Pallero Castillo, Berta Saez Gimenez, Mònica Sánchez Ortiz, María Guadalupe Silveira, Ana Villar | Nursing, technical and administrative staff Daniel Alvarez Simon, Irene Belmonte Mula, Marta Castro de la Visitación, Roser Escobar Fonielles,Sonia Lopez Rodriguez, Emma Lucy Patricia Chang Macchiu, Vicente Ramon Cortina Giner, Cristina Esquinas López, Rosa Lloria Verges, Montserrat Murillo Andres, Thais Pereira Veiga, Maria Antonia Ramon Belmonte, Maria Dolores Untoria Corral
Summary
This year the research programs in this group have been focused in respiratory diseases which present high prevalence and morbidity, as well as important health cost, such as COPD, asthma, sleep apnea, cystic fibrosis or hypersensitivity pneumonitis. Among the most relevant contributions of the group during 2015, it should be noted the participation in the edition of the international clinical guides for COPD, studies about asthma and air pollution or studies focused on the effects of sleep apnea in elders, and the application of precision medicine for the treatment of this pathology. Currently, the Pneumology Service at the Vall d’Hebron University Hospital is one of the leading hospitals in lung transplants in Europe, which has allowed the research group to increase the samples in the pulmonary biobank at Vall d’Hebron, an important platform for future research studies in the field, in pathologies such as COPD, pulmonary fibrosis or cystic fibrosis.